Patel Naimish

Track

Insider profile

Performance

Overall performance
2.0
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -13% 8.2% 15.1%
Success rate 9% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 9%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Patel Naimish's trades of CRISPR Therapeutics AG's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-01 2026-05-29
S Sale
27,723 +13.2%
166.91
US$2,808,852 		27,723 +13.2% 166.91 US$2,808,852
2026-03-17 2026-03-16
S Sale
61,104 -46.4%
390.34
US$4,686,806 		61,104 -46.4% 390.34 US$4,686,806
2025-05-30 2025-05-29
S Sale
90,020 +20.8%
157.59
US$2,368,477 		90,020 +20.8% 157.59 US$2,368,477
2026-01-27 2025-04-03
B Purchase
1,508 +inf%
32.96
US$49,704 		1,508 +inf% 32.96 US$49,704